[1] 应倩,汪媛.肝癌流行现况和趋势分析.中国肿瘤,2020,29:185-191. [2] Ueno K, Miyazono N, Inoue H, et al. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.. Cancer, 2015, 88:1574-1581. [3] 岳元勋, 刘影, 任志忠,等. 明胶海绵微粒TACE治疗Barcelona临床肝癌分期B期肝细胞癌对外周血中髓系来源抑制性细胞的影响. 中国介入影像与治疗学, 2019, 16:280-284. [4] 梁长华,毛华杰,岳军艳,等.肝细胞肝癌CT全肿瘤灌注值与瘤体体积、Child-Pugh分级相关性分析.实用放射学杂志,2018,34:378-381. [5] 中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会, 等.原发性肝癌规范化病理诊断指南(2015年版).解放军医学杂志,2015,40:865-872. [6] 杨怀龙, 雷霆. CT全灌注成像在肝癌TACE介入术前肝储备功能评估中的价值. 肝脏, 2020, 25:270-272. [7] 王刚,卢宗尚.肝动脉化疗栓塞次数对肝癌患者肝功能Child-Pugh分级与肝硬化CT分级的影响.安徽医学,2018,39:981-984. [8] 肖金成, 康鑫鑫, 白淇文,等. 经肝动脉化疗栓塞联合射频消融治疗原发性肝细胞癌合并门静脉癌栓的预后影响因素分析. 中国癌症杂志, 2018, 28: 222-228. [9] Elmoghazy W, Ahmed K, Vijay A, et al. Hepatocellular carcinoma in a rapidly growing community: Epidemiology, clinico-pathology and predictors of extrahepatic metastasis. Arab J Gastroenterol, 2019,20:38-43. [10] 姜正岳,马振波,孔兰玉, 等.CT 灌注成像在肝脏局限性结节状增生和肝细胞肝癌鉴别诊断中的价值.中华消化病与影像杂志(电子版),2015,5:13-16. [11] Chen CW, Hsu LS, Weng JC, et al. Assessment of small hepatocellular carcinoma: perfusion quantification and time-concentration curve evaluation using color-coded and quantitative digital subtraction angiography.. Medicine, 2018,97:133-139. [12] 刘璐璐, 章浙伟, 杨永波,等. CT灌注参数动脉增强分数值在评估肝癌TACE术后疗效中的初步研究. 介入放射学杂志, 2017, 26:988-992. [13] 喻朋辉, 赵香田.双源CT全肝灌注成像用于原发性肝细胞癌患者动脉导管化疗栓塞术后疗效评估研究. 中西医结合肝病杂志, 2018, 28:307-309. [14] 廖碧红, 单鸿, 王劲,等.肝炎后肝硬化继发肝癌患者小肝癌病灶320排CT灌注成像HAP、HPI、HPP变化及其临床意义. 山东医药, 2017,57:14-17. [15] 李珊玫,高知玲,吕茜婷, 等.全肝CT灌注成像定量评估肝癌经肝动脉化疗栓塞术后血流状态变化的价值.中华肝脏病杂志,2018,26:429-435. [16] Ippolito D, Pecorelli A, Querques G, et al. Dynamic computed tomography perfusion imaging: complementary diagnostic tool in hepatocellular carcinoma assessment from diagnosis to treatment follow-up. Acad Radiol, 2019,26:1675-1685. [17] 孙文杰,高知玲,高雨佳,等.基于多层螺旋CT全肝灌注成像小肝癌射频消融术后早期血流状态变化的定量评价.中华肝脏病杂志,2020,28:488-493. |